Naoto Katakami

Glycated Albumin is a Better Indicator for Glucose Excursion than Glycated Hemoglobin in Type 1 and Type 2 Diabetes

Kazutomi Yoshiuchi, Munehide Matsuhisa, Naoto Katakami et al. · Endocrine Journal · 2008 · 193 citations · Full text

Medicine, Biochemistry, Endocrinology +14

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Tomoya Mita, Naoto Katakami, Hidenori Yoshii et al. · Diabetes Care · 2015 · 163 citations

Medicine, Pharmacology, Pharmacotherapy +17

Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients

Naoto Katakami, Munehide Matsuhisa, Hideaki Kaneto et al. · Diabetes Care · 2005 · 157 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa et al. · Diabetes Care · 2016 · 141 citations

Medicine, Endocrinology, Pharmacology +17

Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes

Rieko Hayaishi-Okano, Yoshimitsu Yamasaki, Naoto Katakami et al. · Diabetes Care · 2002 · 130 citations · Full text

Medicine, Clinical Sciences, Endocrinology +15